DANCAN — Dancann Pharma A/S Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Dancann Pharma A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	Interim Report	PRESS
Standards:	DAS	DAS	DAS	DAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.179	21.3	7.74	10.7	2.01
Net Total Accounts Receivable
Net Total Receivables	0.091	7.57	9.17	3.94	1.92
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.293	29.6	17.7	15.7	4.73
Net Property, Plant And Equipment	0.058	3.98	9.57	9.28	8.62
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	0.351	49.5	69	73.1	64.6
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.1	3.86	14.7	10.3	4.13
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	2.1	5.22	15.6	10.3	4.13
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-1.75	44.3	53.4	62.8	60.5
Total Liabilities & Shareholders' Equity	0.351	49.5	69	73.1	64.6
Total Common Shares Outstanding